Norah Clinical Solution was born with a vision to fill the vacuity between the needs of Clinical Community & available products in market. After analyzing & understanding the gaps and weaknesses of currently available health information systems the team recognized the need and resolved to build a new system.
The team created “Elite” A Unified Interoperable Healthcare Platform (UIHP) encompassing the global regulatory standards, regional business processes & tools to simplify the capturing, retrieval and interpretation of administrative, clinical and financial information.
"The Flagship Application “Elite” was created by a team of medical professionals with an average 20 years of experience in design, development & deployment of Clinical Information Systems globally."
The solutions deliver unique insight to improve clinical safety, outcome and reduce cost by identifying duplicate tests, avoiding medication errors, efficient resource utilization and reduced Claims rejections etc
The objective of the Norah Clinical Solution is to assist healthcare providers delivering complex care in a simplified manner.
Norah Clinical Solution is a global healthcare solutions and advisory services company. Our solutions are enabling healthcare delivery organizations to improve clinical outcome, patient safety and patient engagement by built in intelligence and interoperable framework.
Norah Clinical Solution 'Unified Interoperable Healthcare Platform' is built on a leading edge technology. Our team of medical professionals from all specialties are deeply involved from creating & reviewing functional specifications to final testing and delivery of solution to our esteemed customers.
The company is known as NORAH TECHNOLOGIES in UAE OPERATIONS and as NORAH CLINICAL SOLUTION (INDIA) Pvt Ltd in INDIA OPERATIONS.
To deliver simple interoperable, connected care solutions to achieve strategic initiatives.
To simplify & deliver technology for excellence in healthcare and be among the top 3 Healthcare products and solution company in APAC, Africa and Middle East in next 5 years.